This CE marking notification, facilitated through Obelis S.A. as Microbix’s European Authorized Representative, authorizes the placement of REDx HPV Controls (positive controls for types 16, 18, and 45, and a negative control) on the market across Belgium and other EU/EEA Member States. It confirms these NAAT-based in vitro diagnostic products meet the requirements of EU Council Directive 98/79/EC.